Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathis Grossmann

Showing results (161-170 of 189) with videos related to

Pageof 19
Sort By:
European Journal of Endocrinology|July 5, 2023
Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trialKristy P Robledo, Ian C Marschner, David J Handelsman, et al.
Trials|June 21, 2019
Recruitment of men to a multi-centre diabetes prevention trial: an evaluation of traditional and online promotional strategiesKaren Bracken, Wendy Hague, Anthony Keech, et al.
The Medical Journal of Australia|August 12, 2016
Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapyBu B Yeap, Mathis Grossmann, Robert I McLachlan, et al.
The Medical Journal of Australia|September 2, 2016
Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerationsBu B Yeap, Mathis Grossmann, Robert I McLachlan, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2014
Higher serum undercarboxylated osteocalcin and other bone turnover markers are associated with reduced diabetes risk and lower estradiol concentrations in older menBu B Yeap, Helman Alfonso, S A Paul Chubb, et al.
Endocrine Connections|July 31, 2023
Effects of aromatase inhibitor therapy on adiposity and cardiometabolic health in postmenopausal women: a controlled cohort extension studyYee-Ming M Cheung, Rudolf Hoermann, Karen Van, et al.
The Journal of Clinical Endocrinology and Metabolism|February 10, 2025
Testosterone Treatment and Sexual Function in Men: Secondary Analysis of the T4DM (Testosterone for Diabetes) TrialGary A Wittert, Kristy P Robledo, David J Handelsman, et al.
European Journal of Endocrinology|January 10, 2022
Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injectionsDavid J Handelsman, Reena Desai, Ann J Conway, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2024
Denosumab Prevents Bone Loss and Microarchitectural Deterioration in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression Therapy: A Randomized Controlled TrialSabashini K Ramchand, Ali Ghasem-Zadeh, Rudolf Hoermann, et al.
Internal Medicine Journal|August 29, 2018
Hypothyroidism associated with therapy for multi-drug-resistant tuberculosis in AustraliaYee-Ming M Cheung, Karen Van, Lan Lan, et al.
Pageof 19

Showing results (161-170 of 189) with videos related to

Sort By:
Pageof 19
European Journal of Endocrinology|July 5, 2023
Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trialKristy P Robledo, Ian C Marschner, David J Handelsman, et al.
Trials|June 21, 2019
Recruitment of men to a multi-centre diabetes prevention trial: an evaluation of traditional and online promotional strategiesKaren Bracken, Wendy Hague, Anthony Keech, et al.
The Medical Journal of Australia|August 12, 2016
Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapyBu B Yeap, Mathis Grossmann, Robert I McLachlan, et al.
The Medical Journal of Australia|September 2, 2016
Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerationsBu B Yeap, Mathis Grossmann, Robert I McLachlan, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2014
Higher serum undercarboxylated osteocalcin and other bone turnover markers are associated with reduced diabetes risk and lower estradiol concentrations in older menBu B Yeap, Helman Alfonso, S A Paul Chubb, et al.
Endocrine Connections|July 31, 2023
Effects of aromatase inhibitor therapy on adiposity and cardiometabolic health in postmenopausal women: a controlled cohort extension studyYee-Ming M Cheung, Rudolf Hoermann, Karen Van, et al.
The Journal of Clinical Endocrinology and Metabolism|February 10, 2025
Testosterone Treatment and Sexual Function in Men: Secondary Analysis of the T4DM (Testosterone for Diabetes) TrialGary A Wittert, Kristy P Robledo, David J Handelsman, et al.
European Journal of Endocrinology|January 10, 2022
Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injectionsDavid J Handelsman, Reena Desai, Ann J Conway, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2024
Denosumab Prevents Bone Loss and Microarchitectural Deterioration in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression Therapy: A Randomized Controlled TrialSabashini K Ramchand, Ali Ghasem-Zadeh, Rudolf Hoermann, et al.
Internal Medicine Journal|August 29, 2018
Hypothyroidism associated with therapy for multi-drug-resistant tuberculosis in AustraliaYee-Ming M Cheung, Karen Van, Lan Lan, et al.
Pageof 19